These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25168096)

  • 1. Coronary slow-flow phenomenon after paclitaxel-coated balloon angioplasty for neointimal plaque confirmed by optical coherence tomography.
    Yoneyama K; Koyama K; Kongoji K; Mitarai T; Yamazaki H; Kawaguchi H; Takakura N; Kuwata S; Kamijima R; Tanabe Y; Akashi YJ
    Int J Cardiol; 2014 Oct; 176(3):1454-6. PubMed ID: 25168096
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis.
    Yoneyama K; Koyama K; Tanabe Y; Mitarai T; Kamijima R; Kuwata S; Yamazaki H; Nakano E; Kongoji K; Harada T; Akashi YJ
    Int J Cardiol; 2014 Oct; 176(3):1207-9. PubMed ID: 25129263
    [No Abstract]   [Full Text] [Related]  

  • 3. Slow-flow phenomenon after Paclitaxel-coated balloon angioplasty: findings from optical coherence tomography and coronary angioscopy.
    Ikenaga H; Kurisu S; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    JACC Cardiovasc Interv; 2015 Apr; 8(4):e59-62. PubMed ID: 25819189
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete arterial healing 8 years after the implantation of sirolimus-eluting stent. In vivo visualization by optical coherence tomography.
    Bouki KP; Sakkali EK; Apostolou TS
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):625-7. PubMed ID: 21735524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drug-coated balloon angioplasty on in-stent restenotic coronary lesions analyzed with optical coherence tomography and serial coronary artery angioscopy.
    Akutsu N; Ogaku A; Koyama Y; Fujito H; Ebuchi Y; Migita S; Morikawa T; Tamaki T; Mineki T; Kougo T; Kojima K; Iida K; Murata N; Nishida T; Oshima T; Sudo M; Kitano D; Haruta H; Fukamachi D; Takayama T; Hiro T; Hirayama A; Okumura Y
    Heart Vessels; 2019 Dec; 34(12):1925-1935. PubMed ID: 31203393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis.
    Tanaka N; Terashima M; Rathore S; Itoh T; Habara M; Nasu K; Kimura M; Itoh T; Kinoshita Y; Ehara M; Tsuchikane E; Asakura K; Asakura Y; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1074-9. PubMed ID: 20965467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of fragmented balloon materials in coronary arteries by optical coherence tomography.
    Adoni NA; Huang GW; Rangasetty UC; Gilani S; Fujise K
    JACC Cardiovasc Interv; 2014 Jun; 7(6):e65-6. PubMed ID: 24947730
    [No Abstract]   [Full Text] [Related]  

  • 11. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-coated balloon without stent implantation for chronic total occlusion of coronary arteries: Description of a new strategy with an optical coherence tomography assistance.
    Cortese B; Buccheri D; Piraino D; Silva-Orrego P
    Int J Cardiol; 2015 Jul; 191():75-6. PubMed ID: 25965604
    [No Abstract]   [Full Text] [Related]  

  • 14. Very late bare metal stent thrombosis due to neoatherosclerotic plaque rupture: an optical coherence tomography finding.
    Bennett J; Coosemans M; Adriaenssens T
    Heart; 2012 Oct; 98(19):1470. PubMed ID: 22649093
    [No Abstract]   [Full Text] [Related]  

  • 15. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
    Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
    Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical "black hole" phenomenon after treatment of sirolimus stent restenosis with a paclitaxel-coated balloon.
    Linares Vicente JA; Lukic A; Gonzalo López N; Ruiz Arroyo JR
    EuroIntervention; 2012 Apr; 7(12):1479. PubMed ID: 22522559
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue characterization after drug-eluting stent implantation using optical coherence tomography.
    Malle C; Tada T; Steigerwald K; Ughi GJ; Schuster T; Nakano M; Massberg S; Jehle J; Guagliumi G; Kastrati A; Virmani R; Byrne RA; Joner M
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1376-83. PubMed ID: 23539216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical Coherence Tomography in Complicated Coronary Angioplasty.
    Carrillo P; López-Palop R; Cordero A
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):438. PubMed ID: 25487322
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent model.
    Nakamura T; Brott BC; Brants I; Panchal D; Li J; Chen JP; King SB; Chronos N; Hou D
    JACC Cardiovasc Interv; 2011 Feb; 4(2):247-55. PubMed ID: 21349465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
    Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
    Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.